Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF [Phase 3]
Phase 3 trial evaluating prednisone, azathioprine, and N-acetylcysteine in idiopathic pulmonary fibrosis has completed. Results were posted …
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 1]
This update reports the completion of a Phase 1 study of GC1008 (fresolimumab) in patients with Idiopathic Pulmonary Fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Conducting Airways in Lung Fibrosis (VACFI)
A completed clinical trial (NCT01777373) investigating conducting airways in idiopathic pulmonary fibrosis, sponsored by Assistance Publique…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
A Phase 3 trial update reports on the efficacy and safety of pirfenidone in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
This document notes the completion of a Phase 3 study evaluating high-dose N-acetylcysteine in idiopathic pulmonary fibrosis, sponsored by Z…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients [Phase 3]
A Phase 3 trial evaluated high-dose BIBF 1120 (nintedanib) in idiopathic pulmonary fibrosis and reported safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II [Phase 3]
Phase 3 trial evaluating high-dose BIBF 1120 (nintedanib) for idiopathic pulmonary fibrosis has completed. Results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis [Phase 4]
Phase 4 trial investigating 68Ga-DOTA-NOC PET/CT imaging in idiopathic pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients [NA]
ClinicalTrials.gov reports the completed status and posted results of a rehabilitation study in idiopathic pulmonary fibrosis patients.
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial results assess safety and efficacy of BIBF 1120 (nintedanib) in idiopathic pulmonary fibrosis, with sponsor Boehringer Ingelhe…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Safety and PK Study of BIBF 1120 in Japanese Patients With IPF [Phase 2]
A Phase 2 safety and pharmacokinetics study of Boehringer Ingelheim's BIBF 1120 (nintedanib) in Japanese patients with idiopathic pulmonary …
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: IPF Drug Deposition Study [Phase 1]
Phase 1 deposition study for an idiopathic pulmonary fibrosis drug has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 1]
Phase 1b study of IV PRM151 in idiopathic pulmonary fibrosis has completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 trial of sildenafil for idiopathic pulmonary fibrosis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 study assessing the efficacy and safety of pirfenidone in idiopathic pulmonary fibrosis has completed, with reported outcomes on its…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]
This clinical trial update investigates the safety and efficacy of intravenously administered autologous adipose-derived mesenchymal stem ce…
-
CLINICAL_TRIALS trial_result · 2014-04-22Clinical Trial Update: ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 trial ARTEMIS-PH studying ambrisentan for pulmonary hypertension associated with idiopathic pulmonary fibrosis was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF [Phase 3]
The ARTEMIS-IPF Phase 3 trial evaluating ambrisentan for idiopathic pulmonary fibrosis was terminated and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-17Clinical Trial Update: Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study [Phase 2]
A Phase 2 clinical trial evaluated macitentan for idiopathic pulmonary fibrosis; the study has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 trial evaluating an anticoagulant in idiopathic pulmonary fibrosis was terminated, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis [NA]
Clinical trial update on losartan for patients with idiopathic pulmonary fibrosis is completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 trial evaluating sildenafil for exercise performance in idiopathic pulmonary fibrosis completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-29Clinical Trial Update: Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis [Phase 1]
Phase 1 clinical trial of IW001 in idiopathic pulmonary fibrosis has completed; the update summarizes the study status.
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]
This document notes the completion of a Phase 1/2 safety study of tetrathiomolybdate in patients with idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients [Phase 4]
Phase 4 clinical trial update examining the acute effect of sildenafil on exercise tolerance and functional capacity in patients with chroni…